Key Points
Research suggests fewer ETO sterilization suppliers in the US due to stricter regulations and health concerns.
It seems likely that EPA rules and community pressures are key drivers, with potential impacts on medical device availability.
The evidence leans toward challenges for orthopedics, with possible delays in surgeries and higher costs.
Background
Ethylene oxide (ETO) sterilization is crucial for ensuring medical devices, especially in orthopedics, are free from harmful microorganisms. However, the number of ETO sterilization suppliers in the US has been declining, driven by regulatory and environmental pressures.
Reasons for Decline
The decline is largely due to the EPA's 2024 rule aiming to reduce ETO emissions by 90% at nearly 90 facilities, requiring costly upgrades that some cannot afford, leading to closures. Community health concerns, given ETO's carcinogenic properties, have also spurred protests and lawsuits, pushing some facilities to shut down, like Sterigenics in Willowbrook, IL.
Detailed Analysis
To provide a structured overview, the following table summarizes the key drivers and impacts of the decline in ETO sterilization suppliers:
Driver
Descri...
